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ABSTRACT
Context: Adlay seed [Job’s tears, Coix lachryma-jobi L. var. ma-yuen Stapf (Poaceae)] is a Traditional
Chinese Medicine, which has been investigated to treat inflammatory diseases and rheumatism.
Objective: This study evaluates the ameliorative effects of adlay seed extract (ASE) in a complete
Freund’s adjuvant (CFA)-induced rheumatoid arthritis (RA) rats.
Materials and methods: The RA Sprague–Dawley rat model was induced and randomly divided into six
groups with or without ASE treatment (50, 100 or 200mg/kg). After 28 d administration, the symptoms,
biochemical parameters and molecular mechanisms were investigated.
Results: The values of paw oedema, PGE2 and MMP-3 decreased from 1.46±0.04 to 0.66±0.07 cm
3, from
126.2 ± 11.48 to 79.71±6.8 pg/mL and from 142.7 ±8.36 to 86.51 ±5.95ng/mL, respectively; the values of
body weight increased from 177.25 ±5.94 to 205±6.52 g in HASE group. In addition, treatment of ASE
reduced the levels of pro-inflammatory cytokines (IL-1b, TNF-a, IL-6, MCP-1), and increased the activities
of antioxidant enzyme (GSH-Px, SOD, and CAT). Furthermore, ASE could suppress the mRNA expression of
COX-2 and CHI3L1 and improve the mRNA expression of CAT and GPx-1 in ankle tissues of RA rats.
Discussion and conclusions: For the first time, our results indicated ASE exerts anti-RA effects via inhibit-
ing pro-inflammatory factors and alleviating oxidative stress. Our finding sheds light on the research and
development of anti-RA functional foods from adlay seed.
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Introduction
Rheumatoid arthritis (RA) is a systemic and autoimmune disease
characterized by the progressive degradation of cartilage, stiffness
of joints and chronic synovial inflammation (Kumar et al. 2016).
It affects about 1% of the total world population and damages
the linings of joints, leading to joint stiffness and swelling that
can ultimately result in joint deformity and cartilage destruction
(Torpy et al. 2011). The pathogenesis and aetiology of RA
remain not fully understood. Previous evidence indicated that
oxidative stress, inflammation, reactive oxygen species (ROS) and
lipid peroxidation are involved in the severity and progression of
RA (Shahmohamadnejad et al. 2015). Pro-inflammatory cyto-
kines such as interleukin-6 (IL-6), interleukin-1b (IL-1b), tumour
necrosis factor-a (TNF-a) and monocyte chemotactic protein-1
(MCP-1), play a vital role in joint damage during the development
of RA (Umar et al. 2014; Liu et al. 2018). In addition, increased
levels of ROS and oxidative stress at the site of inflammation are
essential to the progression of joint damage (Phull et al. 2018).
Drug therapy, including non-steroidal anti-inflammatory drugs,
disease-modifying anti-rheumatic drugs, biological therapies and
glucocorticoids, remains the main therapies for RA treatment.
Although drug therapy could effectively mitigate the symptoms of
RA, but their clinical application is limited due to the incidence of
side effects, such as gastrointestinal lesions, reproductive toxicity,
infections, and hepatotoxicity (Smolen and Aletaha 2015).
Therefore, novel effective while low-risk RA therapeutic strategy is
urgently required. In this regard, natural medicine with effective
anti-inflammatory and antioxidative effects has been proposed as
an alternative therapy to alleviate the progression and complication
of RA (Abd El-Ghffar et al. 2018; Zhai et al. 2018).
Adlay (Job’s tears, Coix lachryma-jobi L. var. ma-yuen Stapf
(Poaceae)), also known as Yiyimi, is a nourishing food and an
annual crop, as well as a traditional Chinese medicine, which has
been used for the treatment of neuralgia, inflammatory diseases,
rheumatism, osteoporosis, and as a diuretic (Yang et al. 2013).
Polyphenols and polysaccharides are considered to be the major
active components of adlay which possess immunological, anti-
oxidant, and anti-inflammatory effects (Huang et al. 2009; Wang
et al. 2012; Yao et al. 2015). In addition, previous study has indi-
cated that adlay bran extract inhibited the release of inflamma-
tory cytokines and histamines in RBL-2H3 cells (Chen et al.
2012). However, no further pharmacological studies have been
reported on the anti-arthritic ability of ASE on RA.
In present study, for the first time, we investigated the pro-
tective effect of ASE against CFA-induced arthritis in
Sprague–Dawley rats. In addition, we also investigated the anti-
inflammatory and antioxidant effects of ASE. The objective of
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this work was to investigate the underlying mechanisms involved
in the treatment of rheumatoid arthritis diseases.
Materials and methods
Plant materials and reagents
The Coix lachryma-jobi was purchased from Xiamen Hongyi
Chinese Herbal Medicine Wholesale Company (Xiamen, China)
and the seeds of plant material were derived from Jinsha village
of Fujian province and harvested in July 2018, and identified by
Dr Chunfang Zhang. The voucher specimen of Coix lachryma-
jobi (No. 201806) was deposited at Pharmacy College of Xiamen
University. Complete Freund’s adjuvant (CFA) and celecoxib
were purchased from Sigma Aldrich (St. Louis, MO). All other
chemical reagents with analytical grade were purchased from
Aladdin Chemical Reagent Co., Ltd (Shanghai, China).
Preparation of ASE
Dried seed of Coix lachryma-jobi powder (500 g) was extracted
two times with 95% ethanol (5 L each time) at room temperature
for 24 h each time. The combined extract was filtered through
filter paper and the filtrate was concentrated under vacuum at
45 C to obtain a crude extract. Then, the crude extract was sus-
pended in water and defatted with hexane. Then, the water frac-
tion was added into the AB-8 resin for 24 h, and then AB-8 resin
column was eluted with distilled water to remove the polar con-
stituents and then eluted by 80% ethanol. The 80% ethanol elu-
ate was collected and concentrated under vacuum at 45 C, and
then lyophilized at 20 C for 48 h (Huang et al. 2014).
Analysis of the ASE by HPLC
The HPLC analysis was carried out on liquid chromatography
system (Waters 2695, Milford, MA) equipped with a degasser, a
quaternary pumps and photodiode array detection. A Luna C18
(150mm  4.6mm, 5lm) column maintained 30 C, and the
wavelength was recorded at 280 nm. The flow was set 0.8mL/min.
The analysis of mobile phase consisted of methanol (A) and 0.1%
formic acid (B) was applied to gradient elute: 0min, 5% A; 20min,
60% A; 24min, 60% A.
Animals and induction of RA
The 6–8-week-old Sprague–Dawley rats (weighing 180–200 g)
were purchased from the Experimental Animal Centre of
Guangdong Province and housed under laboratory temperature
of 19–24 C, relative humidity 40–60%, and 12 h light/dark cycle.
The rats were allowed freely access to water and basal diets. The
experimental procedures were approved by the Animal Ethics
Committee of Xiamen University (Ethics no. SYXK (Min) 2013-
0006) and animals studies were performed according to National
Institutes of Health Guidelines of United States (National
Research Council of United States, 1996). RA was induced in
rats through the intradermal administration of CFA (0.1mL) at
the palmar surface of the right hind paw on day 0 of the experi-
ment (Abd El-Ghffar et al. 2018). The incomplete Freund’s adju-
vant (IFA) group of rats received intraplantar injection of IFA
(0.1mL). CFA consisted of 1.0mg heat-killed Mycobacterium
tuberculosis (strain H37Ra) suspended in 1mL non-metabolizable
oil, IFA contained non-metabolizable oil only. Paw swelling
occurring in the right hind paw of rats was measured with ver-
nier calliper every 7 days after RA induction. Body weight of rats
were measured once a weekly after RA induction.
Experimental design
Rats were randomly divided into seven groups of eight animals
each as follows: Control group: rats which received the oral
vehicle only (0.1% DMSO) for 28 d. IFA group: rats which
received the oral vehicle (0.1% DMSO) for 28 d. RA group: RA
rats which received the oral vehicle (0.1% DMSO) for 28 d. Cel
group: RA rats which administered celecoxib (5mg/kg/day) for
28 d (Darwish et al. 2014). HASE group: RA rats which adminis-
tered high dose of ASE (200mg/kg/d) for 28 d (Wang et al.
2012). MASE group: RA rats which administered medium dose
of ASE (100mg/kg/d) for 28 d. LASE group: RA rats which
administered low dose of ASE (50mg/kg/d) for 28 d. The treat-
ments were administered consecutively for 28 d starting 1 h after
CFA induction.
Blood and ankle joint tissue sample preparation
At the end of experimental, animals were anaesthetized with
diethyl ether and blood was collected from the retro-orbital sinus
plexus for separation of serum by centrifugation at 4000 rpm for
15min at 3 C, the serum samples were collected and stored at
80 C for further analysis of biochemical estimations. After
that, all rats were sacrificed by cervical dislocation. The ankle
joints were removed and homogenized after adding normal
saline at a ratio of 1:9 (w/v). The homogenate was centrifuged at
4000 rpm for 15min at 3 C and supernatant was collected and
stored at 80 C until further analysis.
Determination of rheumatoid biomarkers
Serum levels of matrix metalloproteinase-3 (MMP3) and prosta-
glandin E2 (PGE2) were measured using commercial kit (Bio-
Rad, Hercules, CA) according to the manufacturer’s instruction.
Measurement of cytokines level
Serum levels of pro-inflammatory cytokines such as IL-1b,
TNF-a, IL-6 and MCP-1 were measured using commercial kit
(Bio-Rad, Hercules, CA) according to the manufacturer’s guide.
Determination of oxidative stress markers
Serum superoxide dismutase (SOD), glutathione peroxidase
(GSH-Px) and catalase (CAT) levels and the serum level of malo-
naldehyde (MDA) were measured using commercial kit (Nanjing
Jiancheng Bioengineering Institute, Nanjing, China) according to
the manufacturer’s instruction.
Quantitative real-time polymerase chain reaction (qRT-PCR)
for gene expression
The mRNA expression of CHI3L1, COX-2, GPX-1 and CAT in
the ankle joint tissue was measured using qRT-PCR as described
previously (Huang et al. 2019; Izu et al. 2019). Total RNA was
extracted from frozen ankle joint with Trizol Reagent (Takara,
Dalian, China) following the manufacturer’s instructions. cDNA
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synthesis was performed with Frist Strand cDNA Synthesis Kit
(Takara, Dalian, China). SYBR Green qPCR Master Mix kit
(Thermo Scientific, Wilmington, DE) was used to quantify the
mRNA levels. The qPCR was performed in triplicates, the par-
ameter of RT-PCR amplification reaction as follows: 40 cycles
of 95 C for 10 s (denaturation) and 72 C for 30 s (annealing/
extension) using the primer sequences (Table 1). The levels of
mRNA expression were normalized to endogenous control
gene GAPDH.
The data statistical analysis
Experimental results were reported as the means ± standard devi-
ation (SD) and the statistical analyses were carried out using
GraphPad Prism Software (GraphPad software, Inc., La Jolla,
CA). The differences between groups were evaluated using one-
way ANOVA followed by Tukey’s multiple comparison test.
p< 0.05 was usually regarded as statistically significant.
Results
Analysis of ASE by HPLC
The chromatogram of ASE indicated the presence of chlorogenic
acid (2), p-coumaric acid (3), caffeic acid (4), and ferulic acid (5)
at 280 nm as obtained with C18 (Figure 1). There are 7 peaks
between 0 and 24min, with relative area of (1) 19.50%, (2)
0.31%, (3) 47.42%, (4) 2.05%, (5) 28.84%, (6) 0.64% and
(7) 1.25%.
Effects of ASE on paw oedema and body weight in CFA-
induced RA rats
To assess the therapeutic effect of ASE on CFA-induced RA, the
paw oedema and the body weight loss of rats in different groups
were measured. As shown in Figure 2(A), after the intradermal
administration of CFA, the model group rats developed severe
paw oedema when compared with those in control group
(p< 0.01). As expected, administration of ASE at different doses
(100 and 200mg/kg/d) obviously decreased paw oedema
Table 1. Primer sequences for quantitative real-time RNA analysis.
Genes Forward primer Reverse primer
CHI3L1 50-GAGCTGCTTCCCAGATGCCC-30 50-CATGCCATACAGGGTTACGTC-30
COX-2 50-CTCTTCCGAGCTGTGCTGC-30 50-TGTGTTTGGGGTGGGCTTC-30
GPX-1 50-TGAGAAGTGCGAGGTGAATG-30 50-CGGGGACCAAATGATGTACT-30
CAT 50-CCTCAGAAACCCGATGTCCTG-30 50-GTCAAAGTGTGCCATCTCGTCG-30
GAPDH 50-CAACTTTGGCATTGTGGAAGG-30 50-ACACATTGGGGGTAGGAACAC-30
Figure 1. The chromatogram of adlay seed (Coix lachryma-jobi L.) extract (ASE) by HPLC analysis. Peak: chlorogenic acid (2), p-coumaric acid (3), caffeic acid (4), and
ferulic acid (5).
Figure 2. Effect of ASE on paw oedema and body weight changes in Freund’s Complete Adjuvant induced arthritis rats. (A) Paw oedema on different days of various
experimental animals. (B) Average changes in body weight. Data are shown as mean± SD (n¼ 8). Differences were analyzed using one-way analysis of variance fol-
lowed by Tukey’s multiple comparison test. #p< 0.01 versus the control group, p< 0.05 versus the RA group, p< 0.01 versus the RA group.
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compared to the RA group (all p< 0.05). Additionally, in the RA
group, there was a significant decrease of body weight compared
to the control group (p< 0.01), which was slightly inhibited by
administration of ASE (Figure 2(B)). Apparently, the therapeutic
effect of ASE treatment on RA rats was comparable to that of
celecoxib, especially in the HASE group (200mg/kg/d).
Effects of ASE on serum PGE2 and MMP-3 levels in CFA-
induced RA rats
As shown in Figure 3, the intradermal administration of CFA
obviously increased serum levels of PGE2 and MMP-3 as com-
pared to the control group (p< 0.01). As expected, administra-
tion of ASE at different doses (100 and 200mg/kg/d) obviously
decreased serum PGE2 and MMP-3 levels as compared to the
RA group (all p< 0.05). Apparently, the suppressive effect of the
ASE treatment group on serum levels of PGE2 and MMP-3 was
comparable to that of the celecoxib group, especially in the
HASE group (200mg/kg/d).
Effect of ASE on serum pro-inflammatory cytokines in CFA-
induced RA rats
As shown in Figure 4, the intradermal administration of CFA
obviously increased serum levels of IL-1b, TNF-a, IL-6 and
MCP-1 as compared to the control group (p< 0.01). As
expected, administration of ASE at different doses (100 and
200mg/kg/d) obviously decreased serum IL-1b, TNF-a, IL-6 and
MCP-1 levels as compared to the RA group (all p< 0.05).
Notably, the suppressive effect of the HASE treatment group
(200mg/kg/d) on serum levels of IL-1b, TNF-a, IL-6 and MCP-1
was comparable to that of the celecoxib group.
Effect of ASE on oxidative stress in CFA-induced RA rats
As displayed in Figure 5, the intradermal administration of CFA
developed an oxidative stress in the shape of decreased activities
of antioxidase (GSH-Px, SOD and CAT) and increased serum
MDA level of RA rats as compared to the control group
(p< 0.01). However, these toxic effects associated with signs of
Figure 3. Effect of ASE on serum levels of PGE2 (A) and MMP-3 (B) in Freund’s Complete Adjuvant induced arthritis rats. Data are shown as mean± SD (n¼ 8).
Differences were analyzed using one-way analysis of variance followed by Tukey’s multiple comparison test. #p< 0.01 versus the control group, p< 0.05 versus the
RA group, p< 0.01 versus the RA group.
Figure 4. Effect of ASE on serum levels of pro-inflammatory cytokines in Freund’s Complete Adjuvant induced arthritis rats. Data are shown as mean± SD (n¼ 8).
Differences were analyzed using one-way analysis of variance followed by Tukey’s multiple comparison test. #p< 0.01 versus the control group, p< 0.05 versus the
RA group, p< 0.01 versus the RA group.
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arthritis were observed to be obviously improved by ASE treat-
ment. As expected, administration of ASE at different doses (50,
100, and 200mg/kg/d) obviously decreased serum MDA level
and enhanced the activities of antioxidase as compared to the
RA group (all p< 0.05), implying that ASE might exert anti-RA
effect via assuaging oxidative stress in CFA-induced RA rats.
Effect of ASE on mRNA expression of COX-2 (a), CHI3L1 (B),
CAT (C), and GPX-1 (D) in CFA-induced RA rats
As shown in Figure 6, the mRNA expression levels of CAT and
GPX-1 were dramatically decreased and mRNA expression levels
of COX-2 and CHI3L1 were obviously increased in the RA
group as compared to the control group (p< 0.01). HASE treat-
ment markedly up-regulated mRNA expression levels of CAT
and GPX-1 and down-regulated mRNA expression levels of
COX-2 and CHI3L1 as compared to the RA group (p< 0.05).
Discussion
RA is a chronic systemic inflammatory disease, which chiefly
attacks the cartilage and joints. Despite the pathogenesis of RA is
still unknown, several epidemiological studies have revealed pro-
inflammatory cytokines and altered oxidative stress play an
important role in the pathogenesis of RA (Schett and Gravallese
2012; Luczaj et al. 2016). CFA-induced RA is widely used animal
model that recapitulates human RA characteristics such as joint
damage, oxidative stress and increment of pro-inflammatory fac-
tors (Asquith et al. 2009; Ren et al. 2019a). In our study, CFA-
induced injection resulted in an obvious joint damage manifested
by oxidative stress, increment of pro-inflammatory factors and
joint swelling. Interestingly, our results revealed that ASE signifi-
cantly suppressed clinical sign of paw oedema, markedly reduced
the oxidative stress and alleviated inflammatory response in
CFA-induced RA rats. In addition, the HPLC analysis of the
ASE revealed the presence of chlorogenic acid, p-coumaric acid,
caffeic acid, and ferulic acid. In accordance with our findings,
previous studies have indicated that treatment with p-coumaric
acid, caffeic acid or ferulic acid attenuated joint swelling in
RA rats (Zhu et al. 2018; Fikry et al. 2019; Ganesan and
Rasool 2019).
Previous literatures have indicated that the increased serum lev-
els of PGE2 and MMP-3 attributed to inflammatory response and
oxidative stress in RA (Bae et al. 2003; Ren et al. 2019b). An
increased serum MMP-3 level is a sign of cartilage destruction in
the early RA (Yamanaka et al. 2000). Synovium-lining cells gener-
ate MMP-3, which plays a vital role in the degradation of type IX
collagen and cartilage proteoglycans, and activates pro-collagenases
(Okada et al. 1989). In the present study, the serum PGE2 and
MMP-3 were obviously increased in CFA-induced RA rats, admin-
istration of ASE significantly reduced serum RA markers namely
PGE2 and MMP-3.
Inflammation is a primary mechanism for CFA-induced RA
rats. Infiltration of pro-inflammatory cytokines and inflammation
play a vital role in the pathogenesis of RA (Schett and Gravallese
2012). The complicated network of chemokines and cytokines in
the development of RA is formed through the co-adjustment in
secretion and synthesis. Pro-inflammatory factors such as IL-1b,
TNF-a, IL-6 and MCP-1 are considered as the primary participa-
tors which are responsible for the prolonged synovial inflamma-
tion, and eventually caused cartilage damage (Chen et al. 2019).
Our results indicated that treatment of ASE obviously declined
the serum levels of IL-1b, TNF-a, IL-6 and MCP-1, implying the
anti-RA effect of ASE was partially via the inhibition of pro-
inflammatory cytokines in CFA-induced RA rats.
CHI3L1 is a chitinase-like glycoprotein expressed in the syn-
ovial tissue, which has been positively related to inflammatory
Figure 5. Effect of ASE on oxidative stress in Freund’s Complete Adjuvant induced arthritis rats. Data are shown as mean± SD (n¼ 8). Differences were analyzed using
one-way analysis of variance followed by Tukey’s multiple comparison test. #p< 0.01 versus the control group, p< 0.05 versus the RA group, p< 0.01 versus the
RA group.
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response and RA disease (Recklies et al. 2005). Previous study
has reported that the serum CHI3L1 level has been considered as
a biomarker for RA disease diagnose which embodies inflamma-
tory level of RA patients (Fikry et al. 2019). COX-2 is an important
enzyme participated in the generation of pro-inflammatory factors
and the destruction of cartilage (Yoon et al. 2013). The present
study revealed that an increase of serum pro-inflammatory cyto-
kines accompanying with upregulation the expression of COX-2
and CHI3L1in RA rats, and similar findings were demonstrated by
previous studies (Fikry et al. 2019; Ren et al. 2019a). Our results
indicated that treatment of ASE obviously reduced the mRNA
expression of COX-2 and CHI3L1 in RA rats, which may be attrib-
uted to the presence of phenolic compounds in ASE. In accordance
with our findings, previous studies have indicated that treatment
with phenolic compounds down-regulated the mRNA expression
of COX-2 and CHI3L1 (Youn et al. 2017; Fikry et al. 2019).
Recent study showed that lipid peroxidation is another mech-
anism of the damage that happened during the RA and the levels
of lipid peroxidation are increased in RA patients (Sarban et al.
2005). Organism possesses an antioxidant defence system in
order to protect tissue from oxidative injure. However, the activ-
ities of antioxidant enzyme have been reported to be decreased
both in RA animals and patients (Seven et al. 2008; Mateen et al.
2019). GPx-1 is generally expressed by most tissues and it pro-
tects cells against oxidative stress (Soriano-Garcia 2004). ASE has
been reported to have free radical scavenging and antioxidant
effects (Wang et al. 2016). In the present study, we observed that
CFA resulted in an obvious depletion in GSH-Px, SOD and CAT
levels and increase in MDA level. And those findings are in
accordance with previous study (Ren et al. 2019a). Our findings
revealed that the protective action of ASE was mediated through
the improvement of antioxidant defence system and inhibiting
the lipid peroxidation level.
In conclusion, the present study revealed the protective effect
of ASE against paw oedema in CFA-induced RA rats. In particu-
lar, the prophylactic effects against rheumatoid arthritis were
mediated via inhibiting pro-inflammatory cytokine, alleviating
oxidative stress, and down-regulating the expression of COX-2
and CHI3L1. Therefore, ASE may be a potential therapeutic
agent for rheumatoid arthritis in clinical application.
Disclosure statement
No potential conflict of interest was reported by the authors.
References
Abd El-Ghffar EA, Eldahshan OA, Barakat A, Efferth T. 2018. The prophylactic
effect of a Eugenia aquea extract against oxidative stress and inflammation
associated with the development of arthritis in an adjuvant-induced arthritis
rat model. Food Funct. 9(12):6643–6651.
Asquith DL, Miller AM, McInnes IB, Liew FY. 2009. Animal models of
rheumatoid arthritis. Eur J Immunol. 39(8):2040–2044.
Bae SC, Kim SJ, Sung MK. 2003. Inadequate antioxidant nutrient intake and
altered plasma antioxidant status of rheumatoid arthritis patients. J Am
Coll Nutr. 22(4):311–315.
Chen HJ, Lo YC, Chiang W. 2012. Inhibitory effects of adlay bran (Coix
lachryma-jobi var. ma-yuen Stapf) on chemical mediator release and cyto-
kine production in rat basophilic leukemia cells. J Ethnopharmacol.
141(1):119–127.
Chen Z, Bozec A, Ramming A, Schett G. 2019. Anti-inflammatory and
immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol.
15(1):9–17.
Darwish HA, Arab HH, Abdelsalam RM. 2014. Chrysin alleviates testicular
dysfunction in adjuvant arthritic rats via suppression of inflammation and
apoptosis: comparison with celecoxib. Toxicol Appl Pharm. 279(2):
129–140.
Fikry EM, Gad AM, Eid AH, Arab HH. 2019. Caffeic acid and ellagic acid
ameliorate adjuvant-induced arthritis in rats via targeting inflammatory
signals, chitinase-3-like protein-1 and angiogenesis. Biomed
Pharmacother. 110:878–886.
Ganesan R, Rasool M. 2019. Ferulic acid inhibits interleukin 17-dependent
expression of nodal pathogenic mediators in fibroblast-like synoviocytes of
rheumatoid arthritis. J Cell Biochem. 120(2):1878–1893.
Huang DW, Kuo YH, Lin FY, Lin YL, Chiang W. 2009. Effect of adlay (Coix
lachryma-jobi var. ma-yuen Stapf) Testa and its phenolic components on
Cu2þ-treated low-density lipoprotein (LDL) oxidation and lipopolysac-
charide (LPS)-induced inflammation in RAW 264.7 macrophages. J Agric
Food Chem. 57(6):2259–2266.
Figure 6. Effect of ASE on mRNA expression of COX-2 (A), CHI3L1 (B), CAT (C), and GPX-1 (D) in Freund’s Complete Adjuvant induced arthritis rats. Data are shown as
mean± SD (n¼ 8). Differences were analyzed using one-way analysis of variance followed by Tukey’s multiple comparison test. #p< 0.01 versus the control group,p< 0.05 versus the RA group, p< 0.01 versus the RA group.
PHARMACEUTICAL BIOLOGY 797
Huang DW, Wu CH, Shih CK, Liu CY, Shih PH, Shieh TM, Lin CI, Chiang
W, Hsia SM. 2014. Application of the solvent extraction technique to
investigation of the anti-inflammatory activity of adlay bran. Food Chem.
145:445–453.
Huang Z, Zheng D, Pu J, Dai J, Zhang Y, Zhang W, Wu Z. 2019.
MicroRNA-125b protects liver from ischemia/reperfusion injury via inhib-
iting TRAF6 and NF-kappaB pathway. Biosci Biotechnol Biochem. 83(5):
829–835.
Izu H, Okuda M, Shibata S, Fujii T, Matsubara K. 2019. Anti-diabetic effect
of S-adenosylmethionine and alpha-glycerophosphocholine in KK-A(y)
mice. Biosci Biotechnol Biochem. 83(4):747–750.
Kumar LD, Karthik R, Gayathri N, Sivasudha T. 2016. Advancement in con-
temporary diagnostic and therapeutic approaches for rheumatoid arthritis.
Biomed Pharmacother. 79:52–61.
Liu W, Sun Y, Cheng Z, Guo Y, Liu P, Wen Y. 2018. Crocin exerts anti-
inflammatory and anti-arthritic effects on type II collagen-induced arth-
ritis in rats. Pharm Biol. 56(1):209–216.
Luczaj W, Gindzienska-Sieskiewicz E, Jarocka-Karpowicz I, Andrisic L,
Sierakowski S, Zarkovic N, Waeg G, Skrzydlewska E. 2016. The onset of
lipid peroxidation in rheumatoid arthritis: consequences and monitoring.
Free Radical Res. 50:304–313.
Mateen S, Shahzad S, Ahmad S, Naeem SS, Khalid S, Akhtar K, Rizvi W,
Moin S. 2019. Cinnamaldehyde and eugenol attenuates collagen induced
arthritis via reduction of free radicals and pro-inflammatory cytokines.
Phytomedicine. 53:70–78.
Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. 1989.
Immunolocalization of matrix metalloproteinase 3 (stromelysin) in
rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.
Ann Rheum Dis. 48(8):645–653.
Phull AR, Nasir B, Haq IU, Kim SJ. 2018. Oxidative stress, consequences and
ROS mediated cellular signaling in rheumatoid arthritis. Chem-Biol
Interact. 281:121–136.
Recklies AD, Ling H, White C, Bernier SM. 2005. Inflammatory cytokines
induce production of CHI3L1 by articular chondrocytes. J Biol Chem.
280(50):41213–41221.
Ren SX, Zhan B, Lin Y, Ma DS, Yan H. 2019a. Selenium nanoparticles dis-
persed in phytochemical exert anti-inflammatory activity by modulating
catalase, GPx1, and COX-2 gene expression in a rheumatoid arthritis rat
model. Med Sci Monit. 25:991–1000.
Ren SX, Zhang B, Lin Y, Ma DS, Li H. 2019b. Mechanistic evaluation of
anti-arthritic activity of beta-methylphenylalanine in experimental rats.
Biomed Pharmacother. 113:108730.
Sarban S, Kocyigit A, Yazar M, Isikan UE. 2005. Plasma total antioxidant
capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities
in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem.
38(11):981–986.
Schett G, Gravallese E. 2012. Bone erosion in rheumatoid arthritis: mecha-
nisms, diagnosis and treatment. Nat Rev Rheumatol. 8(11):656–664.
Seven A, Guzel S, Aslan M, Hamuryudan V. 2008. Lipid, protein, DNA oxi-
dation and antioxidant status in rheumatoid arthritis. Clin Biochem.
41(7–8):538–543.
Shahmohamadnejad S, Vaisi-Raygani A, Shakiba Y, Kiani A, Rahimi Z,
Bahrehmand F, Shakiba E, Pourmotabbed T. 2015. Association between
butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene
polymorphism and their enzymatic activity with severity of rheumatoid
arthritis: correlation with systemic inflammatory markers and oxidative
stress, preliminary report. Clin Biochem. 48:63–69.
Smolen JS, Aletaha D. 2015. Rheumatoid arthritis therapy reappraisal: strat-
egies, opportunities and challenges. Nat Rev Rheumatol. 11(5):276–289.
Soriano-Garcia M. 2004. Organoselenium compounds as potential therapeutic
and chemopreventive agents: a review. CMC. 11(12):1657–1669.
Torpy JM, Perazza GD, Golub RM. 2011. JAMA patient page. Rheumatoid
arthritis. JAMA. 305(17):1824.
Umar S, Umar K, Sarwar AH, Khan A, Ahmad N, Ahmad S, Katiyar CK,
Husain SA, Khan HA. 2014. Boswellia serrata extract attenuates inflamma-
tory mediators and oxidative stress in collagen induced arthritis.
Phytomedicine. 21(6):847–856.
Wang L, Chen C, Su A, Zhang Y, Yuan J, Ju X. 2016. Structural characteriza-
tion of phenolic compounds and antioxidant activity of the phenolic-rich
fraction from defatted adlay (Coix lachryma-jobi. var. ma-yuen Stapf) seed
meal. Food Chem. 196:509–517.
Wang L, Sun J, Yi Q, Wang X, Ju X. 2012. Protective effect of polyphenols
extract of adlay (Coix lachryma-jobi var. ma-yuen Stapf) on hypercholes-
terolemia-induced oxidative stress in rats. Molecules. 17(8):8886–8897.
Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A,
Kamatani N. 2000. Serum matrix metalloproteinase 3 as a predictor of the
degree of joint destruction during the six months after measurement, in
patients with early rheumatoid arthritis. Arthritis Rheum. 43(4):852–858.
Yang RS, Lu YH, Chiang W, Liu SH. 2013. Osteoporosis prevention by adlay
(Yi Yi: The seeds of Coix Lachryma-Jobi var. ma-yuen Stapf) in a mouse
model. J Tradit Complement Med. 3(2):134–138.
Yao Y, Zhu Y, Gao Y, Ren G. 2015. Effect of ultrasonic treatment on
immunological activities of polysaccharides from adlay. Int J Biol
Macromol. 80:246–252.
Yoon HY, Lee EG, Lee H, Cho IJ, Choi YJ, Sung MS, Yoo HG, Yoo WH.
2013. Kaempferol inhibits IL-1beta-induced proliferation of rheumatoid
arthritis synovial fibroblasts and the production of COX-2, PGE2 and
MMPs. Int J Mol Med. 32(4):971–977.
Youn SH, Kwon JH, Yin J, Tam LT, Ahn HS, Myung SC, Lee MW. 2017.
Anti-inflammatory and anti-urolithiasis effects of polyphenolic com-
pounds from Quercus gilva blume. Molecules. 22(7):1121.
Zhai KF, Duan H, Khan GJ, Xu H, Han FK, Cao WG, Gao GZ, Shan LL,
Wei ZJ. 2018. Salicin from Alangium chinense ameliorates rheumatoid
arthritis by modulating the Nrf2-HO-1-ROS pathways. J Agric Food
Chem. 66(24):6073–6082.
Zhu H, Liang QH, Xiong XG, Wang Y, Zhang ZH, Sun MJ, Lu X, Wu D.
2018. Anti-inflammatory effects of p-coumaric acid, a natural compound
of Oldenlandia diffusa, on arthritis model rats. Evid Based Complement
Alternat Med. 2018:5198594.
798 C. ZHANG ET AL.
